ANIKAnika Therapeutics, Inc.

Nasdaq anikatherapeutics.com


$ 25.44 $ -0.26 (-1.01 %)    

Thursday, 18-Apr-2024 15:59:24 EDT
QQQ $ 422.80 $ -4.11 (-0.96 %)
DIA $ 377.76 $ 0.39 (0.1 %)
SPY $ 499.54 $ -1.03 (-0.21 %)
TLT $ 88.82 $ -0.45 (-0.5 %)
GLD $ 220.32 $ 0.75 (0.34 %)
$ 25.43
$ 25.75
$ 0.00 x 0
$ 0.00 x 0
$ 25.43 - $ 25.79
$ 16.54 - $ 28.58
83,322
na
372.7M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-15-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-16-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-11-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-05-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-07-2020 06-30-2020 10-Q
16 05-22-2020 03-31-2020 10-Q
17 03-06-2020 12-31-2019 10-K
18 10-28-2019 09-30-2019 10-Q
19 07-26-2019 06-30-2019 10-Q
20 05-06-2019 03-31-2019 10-Q
21 02-27-2019 12-31-2018 10-K
22 10-26-2018 09-30-2018 10-Q
23 07-31-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 02-27-2018 12-31-2017 10-K
26 10-27-2017 09-30-2017 10-Q
27 07-28-2017 06-30-2017 10-Q
28 05-04-2017 03-31-2017 10-Q
29 02-24-2017 12-31-2016 10-K
30 11-01-2016 09-30-2016 10-Q
31 08-01-2016 06-30-2016 10-Q
32 05-03-2016 03-31-2016 10-Q
33 03-10-2016 12-31-2015 10-K
34 11-03-2015 09-30-2015 10-Q
35 08-04-2015 06-30-2015 10-Q
36 05-04-2015 03-31-2015 10-Q
37 03-13-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-04-2014 06-30-2014 10-Q
40 05-05-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barrington-research-maintains-outperform-on-anika-therapeutics-raises-price-target-to-37

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and raises the pric...

 stephens--co-reiterates-equal-weight-on-anika-therapeutics-maintains-22-price-target

Stephens & Co. analyst George Sellers reiterates Anika Therapeutics (NASDAQ:ANIK) with a Equal-Weight and maintains $22 ...

 anika-therapeutics-q4-2023-adj-eps-005-beats-026-estimate-sales-42971m-beat-41405m-estimate

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(...

 anika-therapeutics-sees-fy24-revenue-168m-173m-vs-17942m-est

Fiscal 2024 GuidanceIn 2024, Anika is prioritizing accelerated growth in profitability, with a focus on the products with the g...

 earnings-scheduled-for-march-13-2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

 barrington-research-maintains-outperform-on-anika-therapeutics-raises-price-target-to-29

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and raises the pric...

 anika-announces-first-surgeries-performed-using-the-integrity-implant-system-a-regenerative-hyaluronic-acid-based-patch-system-for-rotator-cuff-repairs-commencing-limited-market-release

Integrity marks Anika's entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion o...

 barrington-research-maintains-outperform-on-anika-therapeutics-raises-price-target-to-28

Barrington Research analyst Michael Petusky maintains Anika Therapeutics (NASDAQ:ANIK) with a Outperform and raises the pric...

 anika-therapeutics-q3-sales-4147m-beat-3827m-estimate

Anika Therapeutics (NASDAQ:ANIK) reported quarterly sales of $41.47 million which beat the analyst consensus estimate of $38.27...

 earnings-scheduled-for-november-2-2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 164 companies achieved new lows for the year.

 barrington-research-upgrades-anika-therapeutics-to-outperform-announces-24-price-target

Barrington Research analyst Michael Petusky upgrades Anika Therapeutics (NASDAQ:ANIK) from Market Perform to Outperform and ...

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 128 companies set new 52-week lows.

 stephens--co-maintains-equal-weight-on-anika-therapeutics-lowers-price-target-to-23

Stephens & Co. analyst George Sellers maintains Anika Therapeutics (NASDAQ:ANIK) with a Equal-Weight and lowers the pric...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 155 companies set new 52-week lows.

 anika-therapeutics-q2-adj-eps-006-beats-027-estimate-sales-4430m-beat-4056m-estimate

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION